Close

Pfizer (PFE) Announces European Commission Approves LORVIQUA as First-Line Treatment for ALK-Positive Advanced Lung Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/19/2024

1. NFLX
2. TSM
3. ISRG
4. SPY
5. INFY
6. SNV
7. TSLA
8. SMCI
9. SLB
10. PPG


Go back to Pfizer (PFE) Announces European Commission Approves LORVIQUA as First-Line Treatment for ALK-Positive Advanced Lung Cancer
Pfizer Inc. (NYSE: PFE) Delayed: 26.00 +0.61 (2.40%)
Previous Close $25.39    52 Week High $37.39 
Open $25.39    52 Week Low $28.25 
Day High $26.00    P/E 15.76 
Day Low $25.35    EPS $1.65 
Volume 38,358,310